University of Toronto at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
University of Toronto brings 1 presentation to ASH 2026 in New Orleans. Its program centres on thalassemia care now that patients live longer and face new challenges. It covers pregnancy in both transfusion-dependent and non-transfusion-dependent thalassemia.
| Organization | ASH 2026 Attendance |
|---|---|
University of Toronto Toronto, Canada | |
Public research university in Toronto, Ontario, affiliated with the city's major teaching hospitals. | Session Longer Lives, New Challenges: Managing Thalassemia in 2026 Challenges as people with thalassemia live longer, including pregnancy, cheaper and safer gene therapy, and aging with the non-transfusion-dependent form. Talk Pregnancy in Transfusion-Dependent and Non-Transfusion Dependent Thalassemia (TDT and NTDT) Pregnancy risks for women with thalassemia, whether or not they need regular transfusions, and team-based care from pre-conception counseling to after delivery. |
Instantly find 20 buyers from University of Toronto
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction